TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Hospital-Acquired Disease Testing Market, Global Outlook and Forecast 2024-2030

Hospital-Acquired Disease Testing Market, Global Outlook and Forecast 2024-2030

  • Category:Life Sciences
  • Published on : 26 March 2024
  • Pages :82
  • Formats:
  • Report Code:SMR-7929633
OfferClick for best price

Best Price: $2600

HospitalAcquired Disease Testing Market Size, Share 2024


Market size in 2023 US$ 464.3 million
Forecast Market size by 2030 US$ 676.5 million
Growth Rate CAGR of 5.5% Number of Pages 82 Pages

This research report provides a comprehensive analysis of the Hospital-Acquired Disease Testing market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Hospital-Acquired Disease Testing market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Hospital-Acquired Disease Testing, challenges faced by the industry, and potential opportunities for market players.

The global Hospital-Acquired Disease Testing market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Hospital-Acquired Disease Testing market presents opportunities for various stakeholders, including Small and Medium Sized Hospitals, Large Sized Hospitals. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Hospital-Acquired Disease Testing market. Additionally, the growing consumer demand present avenues for market expansion.

The global Hospital-Acquired Disease Testing market was valued at US$ 464.3 million in 2023 and is projected to reach US$ 676.5 million by 2030, at a CAGR of 5.5% during the forecast period.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Key Features:

The research report on the Hospital-Acquired Disease Testing market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.

Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Hospital-Acquired Disease Testing market.

Market Overview: The report provides a comprehensive overview of the Hospital-Acquired Disease Testing market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., UTI Testing, SSI Testing), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.

Market Dynamics: The report analyses the market dynamics driving the growth and development of the Hospital-Acquired Disease Testing market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Hospital-Acquired Disease Testing market's trajectory.

Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Hospital-Acquired Disease Testing market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.

Market Segmentation and Forecast: The report segment the Hospital-Acquired Disease Testing market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.

Technological Trends: The report should highlight the key technological trends shaping the Hospital-Acquired Disease Testing market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.

Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Hospital-Acquired Disease Testing market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.

Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Hospital-Acquired Disease Testing, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.

Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Hospital-Acquired Disease Testing market.

Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.

Market Segmentation

Hospital-Acquired Disease Testing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type

UTI Testing

SSI Testing

Pneumococcal Infections Testing

Bloodstream Infections Testing

MRSA Testing

Market segment by Application

Small and Medium Sized Hospitals

Large Sized Hospitals

Global Hospital-Acquired Disease Testing Market Segment Percentages, By Region and Country, 2023 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Major players covered

Diatherix Laboratories

Gen-Probe

Qiagen

F. Hoffmann-La Roche

Cepheid

Life Technologies Corporation

Meridian Biosciences

Cantel Medical Corporation

Nordion

Outline of Major Chapters:

Chapter 1: Introduces the definition of Hospital-Acquired Disease Testing, market overview.

Chapter 2: Global Hospital-Acquired Disease Testing market size in revenue.

Chapter 3: Detailed analysis of Hospital-Acquired Disease Testing company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Hospital-Acquired Disease Testing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: The main points and conclusions of the report.

Report Attributes Report Details
Report Title Hospital-Acquired Disease Testing Market, Global Outlook and Forecast 2024-2030
Market size in 2023 US$ 464.3 million
Forecast Market size by 2030 US$ 676.5 million
Growth Rate CAGR of 5.5%
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2023
Forecast Year 2031
Number of Pages 82 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 Introduction to Research & Analysis Reports
1.1 Hospital-Acquired Disease Testing Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hospital-Acquired Disease Testing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hospital-Acquired Disease Testing Overall Market Size
2.1 Global Hospital-Acquired Disease Testing Market Size: 2023 VS 2030
2.2 Global Hospital-Acquired Disease Testing Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Hospital-Acquired Disease Testing Players in Global Market
3.2 Top Global Hospital-Acquired Disease Testing Companies Ranked by Revenue
3.3 Global Hospital-Acquired Disease Testing Revenue by Companies
3.4 Top 3 and Top 5 Hospital-Acquired Disease Testing Companies in Global Market, by Revenue in 2023
3.5 Global Companies Hospital-Acquired Disease Testing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hospital-Acquired Disease Testing Players in Global Market
3.6.1 List of Global Tier 1 Hospital-Acquired Disease Testing Companies
3.6.2 List of Global Tier 2 and Tier 3 Hospital-Acquired Disease Testing Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Hospital-Acquired Disease Testing Market Size Markets, 2023 & 2030
4.1.2 UTI Testing
4.1.3 SSI Testing
4.1.4 Pneumococcal Infections Testing
4.1.5 Bloodstream Infections Testing
4.1.6 MRSA Testing
4.2 By Type - Global Hospital-Acquired Disease Testing Revenue & Forecasts
4.2.1 By Type - Global Hospital-Acquired Disease Testing Revenue, 2019-2024
4.2.2 By Type - Global Hospital-Acquired Disease Testing Revenue, 2025-2030
4.2.3 By Type - Global Hospital-Acquired Disease Testing Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Hospital-Acquired Disease Testing Market Size, 2023 & 2030
5.1.2 Small and Medium Sized Hospitals
5.1.3 Large Sized Hospitals
5.2 By Application - Global Hospital-Acquired Disease Testing Revenue & Forecasts
5.2.1 By Application - Global Hospital-Acquired Disease Testing Revenue, 2019-2024
5.2.2 By Application - Global Hospital-Acquired Disease Testing Revenue, 2025-2030
5.2.3 By Application - Global Hospital-Acquired Disease Testing Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Hospital-Acquired Disease Testing Market Size, 2023 & 2030
6.2 By Region - Global Hospital-Acquired Disease Testing Revenue & Forecasts
6.2.1 By Region - Global Hospital-Acquired Disease Testing Revenue, 2019-2024
6.2.2 By Region - Global Hospital-Acquired Disease Testing Revenue, 2025-2030
6.2.3 By Region - Global Hospital-Acquired Disease Testing Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Hospital-Acquired Disease Testing Revenue, 2019-2030
6.3.2 US Hospital-Acquired Disease Testing Market Size, 2019-2030
6.3.3 Canada Hospital-Acquired Disease Testing Market Size, 2019-2030
6.3.4 Mexico Hospital-Acquired Disease Testing Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Hospital-Acquired Disease Testing Revenue, 2019-2030
6.4.2 Germany Hospital-Acquired Disease Testing Market Size, 2019-2030
6.4.3 France Hospital-Acquired Disease Testing Market Size, 2019-2030
6.4.4 U.K. Hospital-Acquired Disease Testing Market Size, 2019-2030
6.4.5 Italy Hospital-Acquired Disease Testing Market Size, 2019-2030
6.4.6 Russia Hospital-Acquired Disease Testing Market Size, 2019-2030
6.4.7 Nordic Countries Hospital-Acquired Disease Testing Market Size, 2019-2030
6.4.8 Benelux Hospital-Acquired Disease Testing Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Hospital-Acquired Disease Testing Revenue, 2019-2030
6.5.2 China Hospital-Acquired Disease Testing Market Size, 2019-2030
6.5.3 Japan Hospital-Acquired Disease Testing Market Size, 2019-2030
6.5.4 South Korea Hospital-Acquired Disease Testing Market Size, 2019-2030
6.5.5 Southeast Asia Hospital-Acquired Disease Testing Market Size, 2019-2030
6.5.6 India Hospital-Acquired Disease Testing Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Hospital-Acquired Disease Testing Revenue, 2019-2030
6.6.2 Brazil Hospital-Acquired Disease Testing Market Size, 2019-2030
6.6.3 Argentina Hospital-Acquired Disease Testing Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Hospital-Acquired Disease Testing Revenue, 2019-2030
6.7.2 Turkey Hospital-Acquired Disease Testing Market Size, 2019-2030
6.7.3 Israel Hospital-Acquired Disease Testing Market Size, 2019-2030
6.7.4 Saudi Arabia Hospital-Acquired Disease Testing Market Size, 2019-2030
6.7.5 UAE Hospital-Acquired Disease Testing Market Size, 2019-2030
7 Hospital-Acquired Disease Testing Companies Profiles
7.1 Diatherix Laboratories
7.1.1 Diatherix Laboratories Company Summary
7.1.2 Diatherix Laboratories Business Overview
7.1.3 Diatherix Laboratories Hospital-Acquired Disease Testing Major Product Offerings
7.1.4 Diatherix Laboratories Hospital-Acquired Disease Testing Revenue in Global Market (2019-2024)
7.1.5 Diatherix Laboratories Key News & Latest Developments
7.2 Gen-Probe
7.2.1 Gen-Probe Company Summary
7.2.2 Gen-Probe Business Overview
7.2.3 Gen-Probe Hospital-Acquired Disease Testing Major Product Offerings
7.2.4 Gen-Probe Hospital-Acquired Disease Testing Revenue in Global Market (2019-2024)
7.2.5 Gen-Probe Key News & Latest Developments
7.3 Qiagen
7.3.1 Qiagen Company Summary
7.3.2 Qiagen Business Overview
7.3.3 Qiagen Hospital-Acquired Disease Testing Major Product Offerings
7.3.4 Qiagen Hospital-Acquired Disease Testing Revenue in Global Market (2019-2024)
7.3.5 Qiagen Key News & Latest Developments
7.4 F. Hoffmann-La Roche
7.4.1 F. Hoffmann-La Roche Company Summary
7.4.2 F. Hoffmann-La Roche Business Overview
7.4.3 F. Hoffmann-La Roche Hospital-Acquired Disease Testing Major Product Offerings
7.4.4 F. Hoffmann-La Roche Hospital-Acquired Disease Testing Revenue in Global Market (2019-2024)
7.4.5 F. Hoffmann-La Roche Key News & Latest Developments
7.5 Cepheid
7.5.1 Cepheid Company Summary
7.5.2 Cepheid Business Overview
7.5.3 Cepheid Hospital-Acquired Disease Testing Major Product Offerings
7.5.4 Cepheid Hospital-Acquired Disease Testing Revenue in Global Market (2019-2024)
7.5.5 Cepheid Key News & Latest Developments
7.6 Life Technologies Corporation
7.6.1 Life Technologies Corporation Company Summary
7.6.2 Life Technologies Corporation Business Overview
7.6.3 Life Technologies Corporation Hospital-Acquired Disease Testing Major Product Offerings
7.6.4 Life Technologies Corporation Hospital-Acquired Disease Testing Revenue in Global Market (2019-2024)
7.6.5 Life Technologies Corporation Key News & Latest Developments
7.7 Meridian Biosciences
7.7.1 Meridian Biosciences Company Summary
7.7.2 Meridian Biosciences Business Overview
7.7.3 Meridian Biosciences Hospital-Acquired Disease Testing Major Product Offerings
7.7.4 Meridian Biosciences Hospital-Acquired Disease Testing Revenue in Global Market (2019-2024)
7.7.5 Meridian Biosciences Key News & Latest Developments
7.8 Cantel Medical Corporation
7.8.1 Cantel Medical Corporation Company Summary
7.8.2 Cantel Medical Corporation Business Overview
7.8.3 Cantel Medical Corporation Hospital-Acquired Disease Testing Major Product Offerings
7.8.4 Cantel Medical Corporation Hospital-Acquired Disease Testing Revenue in Global Market (2019-2024)
7.8.5 Cantel Medical Corporation Key News & Latest Developments
7.9 Nordion
7.9.1 Nordion Company Summary
7.9.2 Nordion Business Overview
7.9.3 Nordion Hospital-Acquired Disease Testing Major Product Offerings
7.9.4 Nordion Hospital-Acquired Disease Testing Revenue in Global Market (2019-2024)
7.9.5 Nordion Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Hospital-Acquired Disease Testing Market Opportunities & Trends in Global Market
Table 2. Hospital-Acquired Disease Testing Market Drivers in Global Market
Table 3. Hospital-Acquired Disease Testing Market Restraints in Global Market
Table 4. Key Players of Hospital-Acquired Disease Testing in Global Market
Table 5. Top Hospital-Acquired Disease Testing Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Hospital-Acquired Disease Testing Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Hospital-Acquired Disease Testing Revenue Share by Companies, 2019-2024
Table 8. Global Companies Hospital-Acquired Disease Testing Product Type
Table 9. List of Global Tier 1 Hospital-Acquired Disease Testing Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hospital-Acquired Disease Testing Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Hospital-Acquired Disease Testing Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Hospital-Acquired Disease Testing Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Hospital-Acquired Disease Testing Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Hospital-Acquired Disease Testing Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Hospital-Acquired Disease Testing Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Hospital-Acquired Disease Testing Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2025-2030
Table 30. Diatherix Laboratories Company Summary
Table 31. Diatherix Laboratories Hospital-Acquired Disease Testing Product Offerings
Table 32. Diatherix Laboratories Hospital-Acquired Disease Testing Revenue (US$, Mn) & (2019-2024)
Table 33. Diatherix Laboratories Key News & Latest Developments
Table 34. Gen-Probe Company Summary
Table 35. Gen-Probe Hospital-Acquired Disease Testing Product Offerings
Table 36. Gen-Probe Hospital-Acquired Disease Testing Revenue (US$, Mn) & (2019-2024)
Table 37. Gen-Probe Key News & Latest Developments
Table 38. Qiagen Company Summary
Table 39. Qiagen Hospital-Acquired Disease Testing Product Offerings
Table 40. Qiagen Hospital-Acquired Disease Testing Revenue (US$, Mn) & (2019-2024)
Table 41. Qiagen Key News & Latest Developments
Table 42. F. Hoffmann-La Roche Company Summary
Table 43. F. Hoffmann-La Roche Hospital-Acquired Disease Testing Product Offerings
Table 44. F. Hoffmann-La Roche Hospital-Acquired Disease Testing Revenue (US$, Mn) & (2019-2024)
Table 45. F. Hoffmann-La Roche Key News & Latest Developments
Table 46. Cepheid Company Summary
Table 47. Cepheid Hospital-Acquired Disease Testing Product Offerings
Table 48. Cepheid Hospital-Acquired Disease Testing Revenue (US$, Mn) & (2019-2024)
Table 49. Cepheid Key News & Latest Developments
Table 50. Life Technologies Corporation Company Summary
Table 51. Life Technologies Corporation Hospital-Acquired Disease Testing Product Offerings
Table 52. Life Technologies Corporation Hospital-Acquired Disease Testing Revenue (US$, Mn) & (2019-2024)
Table 53. Life Technologies Corporation Key News & Latest Developments
Table 54. Meridian Biosciences Company Summary
Table 55. Meridian Biosciences Hospital-Acquired Disease Testing Product Offerings
Table 56. Meridian Biosciences Hospital-Acquired Disease Testing Revenue (US$, Mn) & (2019-2024)
Table 57. Meridian Biosciences Key News & Latest Developments
Table 58. Cantel Medical Corporation Company Summary
Table 59. Cantel Medical Corporation Hospital-Acquired Disease Testing Product Offerings
Table 60. Cantel Medical Corporation Hospital-Acquired Disease Testing Revenue (US$, Mn) & (2019-2024)
Table 61. Cantel Medical Corporation Key News & Latest Developments
Table 62. Nordion Company Summary
Table 63. Nordion Hospital-Acquired Disease Testing Product Offerings
Table 64. Nordion Hospital-Acquired Disease Testing Revenue (US$, Mn) & (2019-2024)
Table 65. Nordion Key News & Latest Developments
List of Figures
Figure 1. Hospital-Acquired Disease Testing Segment by Type in 2023
Figure 2. Hospital-Acquired Disease Testing Segment by Application in 2023
Figure 3. Global Hospital-Acquired Disease Testing Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Hospital-Acquired Disease Testing Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Hospital-Acquired Disease Testing Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Hospital-Acquired Disease Testing Revenue in 2023
Figure 8. By Type - Global Hospital-Acquired Disease Testing Revenue Market Share, 2019-2030
Figure 9. By Application - Global Hospital-Acquired Disease Testing Revenue Market Share, 2019-2030
Figure 10. By Type - Global Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Hospital-Acquired Disease Testing Revenue Market Share, 2019-2030
Figure 12. By Application - Global Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Hospital-Acquired Disease Testing Revenue Market Share, 2019-2030
Figure 14. By Region - Global Hospital-Acquired Disease Testing Revenue Market Share, 2019-2030
Figure 15. By Country - North America Hospital-Acquired Disease Testing Revenue Market Share, 2019-2030
Figure 16. US Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Hospital-Acquired Disease Testing Revenue Market Share, 2019-2030
Figure 20. Germany Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2019-2030
Figure 21. France Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Hospital-Acquired Disease Testing Revenue Market Share, 2019-2030
Figure 28. China Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2019-2030
Figure 32. India Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Hospital-Acquired Disease Testing Revenue Market Share, 2019-2030
Figure 34. Brazil Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Hospital-Acquired Disease Testing Revenue Market Share, 2019-2030
Figure 37. Turkey Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2019-2030
Figure 41. Diatherix Laboratories Hospital-Acquired Disease Testing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Gen-Probe Hospital-Acquired Disease Testing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Qiagen Hospital-Acquired Disease Testing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. F. Hoffmann-La Roche Hospital-Acquired Disease Testing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Cepheid Hospital-Acquired Disease Testing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Life Technologies Corporation Hospital-Acquired Disease Testing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Meridian Biosciences Hospital-Acquired Disease Testing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Cantel Medical Corporation Hospital-Acquired Disease Testing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Nordion Hospital-Acquired Disease Testing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount